Evidence map›Paper›PMID 30599299›Full record

ArticleJournal of the neurological sciences2019

Burden of subclinical carotid atherosclerosis and vascular risk factors among people living with HIV in Ghana.

Fred Stephen Sarfo, Michelle Nichols, Benedict Agyei, Arti Singh, Eugenia Ennin, Adu Darko Nyantakyi, Shadrack Osei Asibey, Raelle Tagge, Mulugeta Gebregziabher, Carolyn Jenkins and 1 more

Abstract read
In one paragraph

Article in Journal of the neurological sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 3 pooled it
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 3 syntheses or guidelines pooled it, 30 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Fred Stephen SarfoKwame Nkrumah University of Science & Technology, Kumasi, Ghana; Komfo Anokye Teaching Hospital, Kumasi, Ghana. Electronic address: stephensarfo78@gmail.com.
Michelle NicholsMedical University of South Carolina, Charleston, USA.
Benedict AgyeiKwame Nkrumah University of Science & Technology, Kumasi, Ghana.
Arti SinghKwame Nkrumah University of Science & Technology, Kumasi, Ghana.
Eugenia EnninKomfo Anokye Teaching Hospital, Kumasi, Ghana.
Adu Darko NyantakyiKomfo Anokye Teaching Hospital, Kumasi, Ghana.
Shadrack Osei AsibeyKomfo Anokye Teaching Hospital, Kumasi, Ghana.
Raelle TaggeMedical University of South Carolina, Charleston, USA.
Mulugeta GebregziabherMedical University of South Carolina, Charleston, USA.
Carolyn JenkinsMedical University of South Carolina, Charleston, USA.
Bruce OvbiageleUniversity of California, San Francisco, USA.
Komfo Anokye Teaching Hospital · GHMedical University of South Carolina · USKwame Nkrumah University of Science and Technology · GHUniversity of California, San Francisco · US

Funding

Evaluation of Vascular Event Risk while on Long-term Antiretroviral Suppressive Treatment (EVERLAST)R21TW010479 · FIC · NORTHERN CALIFORNIA INSTITUTE/RES/EDU · PI OVBIAGELE, BRUCE, SARFO, FRED STEPHEN · 2016 to 2017
$312k
FIC NIH HHS R21 TW010479
6 · The paper itself

Abstract

backgroundThe burden of cardiovascular disease (CVD) among people living with HIV (PLWH) in sub-Saharan Africa is projected to rise due to a rapid epidemiological transition and improved treatment of HIV infection on the sub-continent.

objectiveThe Evaluation of Vascular Event Risk while on Long-term Anti-retroviral Suppressive Therapy (EVERLAST) Study sought to assess the extent of subclinical atherosclerosis and characterize the nature of CVD risk factors among HIV patients on Antiretroviral therapy (ART) in Ghana.

methodsWe conducted a cross-sectional study involving HIV patients on antiretroviral therapy (n = 250) in comparison with HIV positive ART naïve (n = 201), and HIV uninfected controls (n = 250). We assessed prevalence of hypertension, dyslipidemia, diabetes mellitus, central obesity, and carotid atherosclerosis using B-mode carotid Doppler ultrasonography. We assessed factors associated with subclinical atherosclerosis defined by a carotid intimal media thickness (CIMT) cut-off of ≥0.78 mm among PLWH using a logistic regression model.

resultsMean age of PLWH on combination ART (cART) was 45.7 ± 8.6 years, 42.9 ± 8.8 years among PLWH not on cART, and 44.9 ± 9.5 years among HIV negative controls of which 81.2%, 81.6% and 81.1% respectively were females. Prevalence of subclinical atherosclerosis at the common carotid artery in the three groups was 67.6%, 66.7% and 62.4%, p = 0.43. Among PLWH, raised serum total cholesterol (OR 1.16, 95% CI: 1.00-1.35) and triglycerides (OR 1.32, 95% CI: 1.01-1.73) were significantly associated with subclinical atherosclerosis. Prevalence of vascular risk factors among PLWH on cART, PLWH cART naïve, and HIV negative controls respectively were as follows: dyslipidemia- 79.5%, 83.1%, and 73.5%, p = 0.04; hypertension- 40.2%, 23.4%, and 44.9%, p < 0.0001; central obesity-61.8%, 66.7%, and 78.2%, p < 0.0001; diabetes mellitus-6.8%, 5.5% and 4.9%, p = 0.53.

conclusionOverall while there is a high baseline prevalence of CVD risk factors in the Ghanaian population, serum lipid derangements appear to be more prevalent among HIV infected patients, and are linked to sub-clinical atherosclerosis. Future studies need to confirm these findings, explore the underlying pathophysiology, and optimize treatment strategies to avert untoward CVD outcomes.

Indexed as

AdultAnti-Retroviral AgentsCardiovascular DiseasesCarotid ArteriesCarotid Artery DiseasesCarotid Intima-Media ThicknessComorbidityCross-Sectional StudiesFemaleGhanaHIV InfectionsHumansMaleMiddle AgedPrevalenceRisk FactorsAnti-Retroviral AgentsCardiovascular riskCarotid atherosclerosisDyslipidemiaHIVStroke

Identifiers

PMID30599299
PMCPMC6368351
OpenAlexW2904027405

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.